L Lexeo Therapeutics, Inc.: insider trades · United States · SEC (Form 4) Discover the full directors' dealings record of Lexeo Therapeutics, Inc., a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €380m. The latest transaction was disclosed on 20 May 2025 (Cession). Among the most active insiders: Townsend Richard Nolan. Every trade is accessible without an account.
Buys €100,050 €49,698 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 20 May 2025
All Executives35 Thresholds0 Prospectus0 Other0
Declarations 35 total
▼ Chief Legal Officer · Executives · 16 May 2025
521 shares @ US$2.774 5.4% of flow Common Stock SEC:0001415889-25-013817:0
▼ Chief Medical Officer · Executives · 16 May 2025
585 shares @ US$2.774 12.7% of flow Common Stock SEC:0001415889-25-013818:0
▼ Chief Executive Officer · Executives · 16 May 2025
1,074 shares @ US$2.774 2.6% of flow Common Stock SEC:0001415889-25-013819:0
▼ Chief Development Officer · Executives · 16 May 2025
367 shares @ US$2.774 4.3% of flow Common Stock SEC:0001415889-25-013816:0
◆ Chief Development Officer · Executives · 14 Mar 2025
5,720 shares @ US$2.61 65.7% of flow Common Stock SEC:0001415889-25-010501:0
◆ Chief Technical Officer · Executives · 14 Mar 2025
5,720 shares @ US$2.61 100.0% of flow Common Stock SEC:0001415889-25-010505:0
◆ Chief Legal Officer · Executives · 14 Mar 2025
5,720 shares @ US$2.61 57.5% of flow Common Stock SEC:0001415889-25-010503:0
◆ Chief Executive Officer · Executives · 14 Mar 2025
2,128 shares @ US$2.61 5.1% of flow Common Stock SEC:0001415889-25-009450:0
▼ Chief Legal Officer · Executives · 19 Feb 2025
2,101 shares @ US$4.413 37.1% of flow Common Stock SEC:0001415889-25-005108:0
▼ Chief Executive Officer · Executives · 19 Feb 2025
4,326 shares @ US$4.413 18.0% of flow Common Stock SEC:0001415889-25-005113:0
▼ Chief Development Officer · Executives · 19 Feb 2025
1,486 shares @ US$4.413 30.0% of flow Common Stock SEC:0001415889-25-005110:0
▼ Chief Medical Officer · Executives · 19 Feb 2025
2,359 shares @ US$4.413 87.3% of flow Common Stock SEC:0001415889-25-005109:0
◆ Chief Financial Officer · Executives · 17 Jan 2025
40,875 shares 0Common Stock SEC:0001415889-25-001859:0
◆ Chief Technical Officer · Executives · 7 Jan 2025
26,250 shares 0Common Stock SEC:0001415889-25-001286:0
◆ Chief Legal & Admin Officer · Executives · 7 Jan 2025
36,250 shares 0Common Stock SEC:0001415889-25-001285:0
◆ Chief Medical Officer · Executives · 7 Jan 2025
43,750 shares 0Common Stock SEC:0001415889-25-001283:0
◆ Chief Executive Officer · Executives · 7 Jan 2025
103,750 shares 0Common Stock SEC:0001415889-25-001287:0
◆ Chief Development Officer · Executives · 7 Jan 2025
38,750 shares 0Common Stock SEC:0001415889-25-001284:0
◇ Chief Executive Officer · Executives · 10 Dec 2024
2,500 shares @ US$2.33 5.5% of flow Common Stock SEC:0001415889-24-029143:0
▲ Director · Executives · 25 Nov 2024
15,000 shares @ US$6.9901 100.0% of flow Common Stock SEC:0001415889-24-027746:0
Ideal exit: 22 Aug 2025 (T+270) ◇ Chief Executive Officer · Executives · 11 Nov 2024
2,500 shares @ US$2.33 5.4% of flow Common Stock SEC:0001415889-24-026737:0
◇ Chief Executive Officer · Executives · 10 Oct 2024
5,000 shares @ US$2.33 10.5% of flow Common Stock SEC:0001415889-24-025110:0
◇ Chief Executive Officer · Executives · 10 Sept 2024
5,000 shares @ US$2.33 10.4% of flow Common Stock SEC:0001415889-24-023233:0
◇ Chief Executive Officer · Executives · 12 Aug 2024
5,000 shares @ US$2.33 10.5% of flow Common Stock SEC:0001415889-24-021245:0
◇ Chief Executive Officer · Executives · 10 Jul 2024
5,000 shares @ US$2.33 10.6% of flow Common Stock SEC:0001415889-24-019526:0
25 of 35 declarations
Load more (10 remaining)